Log in
Enquire now
‌

US Patent 6872700 Methods for glucagon suppression

Patent 6872700 was granted and assigned to Amylin Pharmaceuticals on March, 2005 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Amylin Pharmaceuticals
Amylin Pharmaceuticals
0
Date Filed
January 14, 2000
0
Date of Patent
March 29, 2005
0
Patent Application Number
09889331
0
Patent Citations Received
‌
US Patent 11884713 Acylated glucagon analogues
0
‌
US Patent 12102663 Treatment of post-bariatric hypoglycemia with exendin (9-39)
0
‌
US Patent 12060430 Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)
0
‌
US Patent 11840559 Glucagon-receptor selective polypeptides and methods of use thereof
0
Patent Inventor Names
Bronislava Gedulin
0
Andrew A. Young
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
6872700
0
Patent Primary Examiner
‌
Karen Cochrane Carlson
0

Find more entities like US Patent 6872700 Methods for glucagon suppression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.